Volume 18, Number 9—September 2012
Research
Trends in Meningococcal Disease in the United States Military, 1971–2010
Table 2
Characteristic |
N. meningitidis serogroup, no. (%) cases
|
% Cases | % Total population | Incidence | ||||
---|---|---|---|---|---|---|---|---|
B | C | Y | Unknown | Total | ||||
Total | 6 (23) | 7 (27) | 9 (35) | 4 (15) | 26 | |||
Year of illness | ||||||||
2006 |
0 | 4 | 0 | 2 | 6 | 23 | 20 | 0.440 |
2007 |
2 | 1 | 1 | 1 | 5 | 19 | 20 | 0.367 |
2008 |
3 | 0 | 4 | 1 | 8 | 31 | 20 | 0.581 |
2009 |
1 | 0 | 1 | 0 | 2 | 8 | 20 | 0.142 |
2010 |
0 | 2 | 3 | 0 | 5 | 19 | 20 | 0.354 |
Death | ||||||||
Yes |
2 | 2 | 1 | 0 | 5 | 19 | ||
No |
4 | 5 | 8 | 4 | 21 | 81 | ||
Age range, y | ||||||||
17–19 |
2 | 3 | 4 | 2 | 11 | 42 | 7 | 2.343 |
20–24 |
1 | 3 | 5 | 1 | 10 | 38 | 33 | 0.434 |
25–29 |
1 | 1 | 0 | 1 | 3 | 12 | 23 | 0.188 |
30–34 |
0 | 0 | 0 | 0 | 0 | 0 | 14 | 0.000 |
35–39 |
2 | 0 | 0 | 0 | 2 | 8 | 12 | 0.250 |
>40 |
0 | 0 | 0 | 0 | 0 | 0 | 10 | 0.000 |
Clinical syndrome | ||||||||
Meningitis alone |
2 | 4 | 1 | 4 | 11 | 42 | ||
Sepsis alone |
3 | 1 | 4 | 0 | 8 | 31 | ||
Both |
1 | 2 | 4 | 0 | 7 | 27 | ||
Vaccine type | ||||||||
Conjugate |
3 | 2 | 4 | 1 | 10 | 38 | ||
Polysaccharide |
3 | 4 | 4 | 2 | 13 | 50 | ||
Unknown |
0 | 1 | 1 | 1 | 3 | 12 | ||
Years from vaccination to illness | ||||||||
<1 |
NA | 6 | 7 | 0 | 13 | 81 | ||
1–2 |
NA | 1 | 1 | 0 | 2 | 13 | ||
2–3 |
NA | 0 | 0 | 0 | 0 | 0 | ||
>3 |
NA | 0 | 1 | 0 | 1 | 6 | ||
Military branch | ||||||||
Air Force |
1 | 1 | 0 | 0 | 2 | 8 | 23 | 0.120 |
Army |
2 | 3 | 0 | 0 | 5 | 19 | 37 | 0.189 |
Coast Guard |
1 | 0 | 0 | 0 | 1 | 4 | 3 | 0.509 |
Marine Corps |
2 | 3 | 5 | 3 | 13 | 50 | 14 | 1.353 |
Navy |
0 | 0 | 4 | 1 | 5 | 19 | 23 | 0.302 |
Location | ||||||||
Continental United States |
4 | 5 | 8 | 3 | 20 | 77 | 71 | 0.418 |
Outside continental United States |
2 | 2 | 1 | 1 | 6 | 23 | 29 | 0.310 |
Race/ethnicity | ||||||||
Asian |
1 | 0 | 0 | 0 | 1 | 4 | 4 | 0.328 |
Black |
0 | 3 | 3 | 0 | 6 | 23 | 18 | 0.472 |
Hispanic/Latino |
0 | 0 | 1 | 0 | 1 | 4 | 12 | 0.123 |
White |
3 | 4 | 5 | 4 | 16 | 62 | 61 | 0.367 |
Native American/Alaskan |
0 | 0 | 0 | 0 | 0 | 0 | 2 | 0.000 |
Unknown |
2 | 0 | 0 | 0 | 2 | 8 | 3 | |
Sex | ||||||||
F |
2 | 1 | 1 | 0 | 4 | 15 | 14 | 0.401 |
M |
4 | 6 | 8 | 4 | 22 | 85 | 86 | 0.359 |
Military rank | ||||||||
Recruit |
2 | 1 | 4 | 2 | 9 | 35 | 12 | 1.057 |
Enlisted |
4 | 6 | 5 | 2 | 17 | 65 | 73 | 0.330 |
Officer |
0 | 0 | 0 | 0 | 0 | 0 | 15 | 0.000 |
*Exact denominators are not available in all categories. Percentage values may not equal 100 because of rounding. Boldface indicates that incidence for the category is significantly different from the incidence in the remaining population (Poisson p<0.05). NA, not applicable (no serogroup B vaccine).
Page created: August 15, 2012
Page updated: August 15, 2012
Page reviewed: August 15, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.